These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12506766)

  • 1. [Clinical impact of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of brain diseases].
    Buck A; Kamel E
    Acta Med Austriaca; 2002; 29(5):156-61. PubMed ID: 12506766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional imaging in brain tumors].
    Borbély K
    Orv Hetil; 2004 Feb; 145(8):411-23. PubMed ID: 15061026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [F-18 fluorodeoxyglucose positron emission tomography in neurology].
    Fazekas F; Payer F
    Wien Med Wochenschr; 2002; 152(11-12):293-7. PubMed ID: 12138659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical applications of positron-emission tomography in brain pathology].
    Montz HR
    An R Acad Nac Med (Madr); 1997; 114(2):479-88; discussion 488-9. PubMed ID: 9412253
    [No Abstract]   [Full Text] [Related]  

  • 5. Positron emission tomography of the brain.
    Macapinlac HA
    Neuroimaging Clin N Am; 2006 Nov; 16(4):591-603, viii. PubMed ID: 17148021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
    Bénard F; Romsa J; Hustinx R
    Semin Nucl Med; 2003 Apr; 33(2):148-62. PubMed ID: 12756647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical application of positron emission tomography and 18FDG to brain tumor].
    Momose T
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():242-9. PubMed ID: 16201530
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer.
    Hooft L; Hoekstra OS; Devillé W; Lips P; Teule GJ; Boers M; van Tulder MW
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3779-86. PubMed ID: 11502811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of positron emission tomography for presurgical localization of eloquent brain areas in children with seizures.
    Duncan JD; Moss SD; Bandy DJ; Manwaring K; Kaplan AM; Reiman EM; Chen K; Lawson MA; Wodrich DL
    Pediatr Neurosurg; 1997 Mar; 26(3):144-56. PubMed ID: 9419031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical positron emission tomography: brain imaging].
    Borbély K
    Orv Hetil; 2002 May; 143(21 Suppl 3):1294-7. PubMed ID: 12077920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of a high-resolution (2.6-mm) positron emission tomography.
    Valk PE; Jagust WJ; Derenzo SE; Huesman RH; Geyer AB; Budinger TF
    Radiology; 1990 Sep; 176(3):783-90. PubMed ID: 2389037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.
    Chung JK; Kim YK; Kim SK; Lee YJ; Paek S; Yeo JS; Jeong JM; Lee DS; Jung HW; Lee MC
    Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):176-82. PubMed ID: 11926379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F-18 FDG brain positron emission tomography and Tl-201 early and delayed SPECT in distinguishing atypical cerebral tumor from cerebral infarction.
    Liu HG; Mountz JM
    Clin Nucl Med; 2003 Mar; 28(3):241-2. PubMed ID: 12592141
    [No Abstract]   [Full Text] [Related]  

  • 14. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
    Stokkel M; Stevens H; Taphoorn M; Van Rijk P
    Nucl Med Commun; 1999 May; 20(5):411-7. PubMed ID: 10404525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET and SPECT in brain tumors and epilepsy.
    Horky LL; Treves ST
    Neurosurg Clin N Am; 2011 Apr; 22(2):169-84, viii. PubMed ID: 21435569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in the investigation of central nervous system disorders.
    Jamieson D; Alavi A; Jolles P; Chawluk J; Reivich M
    Radiol Clin North Am; 1988 Sep; 26(5):1075-88. PubMed ID: 3047777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
    Granov AM; Tiushin LA; Tlostanova MS; Kostenikov NA; Ryzhkova DV; Savello VE; Stanzhevskiĭ AA
    Vopr Onkol; 2003; 49(5):563-73. PubMed ID: 14682126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies.
    Pirotte B; Goldman S; Massager N; David P; Wikler D; Lipszyc M; Salmon I; Brotchi J; Levivier M
    J Neurosurg; 2004 Sep; 101(3):476-83. PubMed ID: 15352606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
    Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
    Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18F-fluorodeoxyglucose positron emission tomography in colorectal cancer: value in primary staging and follow-up].
    Jörg L; Heinisch M; Rechberger E; Kurz F; Klug R; Aufschnaiter M; Hammer J; Langsteger W
    Acta Med Austriaca; 2002; 29(5):176-9. PubMed ID: 12506769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.